Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer

Author(s):
Poelgeest, M.I.E. van; Visconti, V.V.; Aghai, Z.; Ham, V.J. van; Heusinkveld, M.; Zandvliet, M.L.; Valentijn, A.R.P.M.; Goedemans, R.; Minne, C.E. van der; Verdegaal, E.M.E. (0000-0002-4449-8707); Trimbos, J.B.M.Z. (0000-0002-8017-2376); Burg, S.H. van der (0000-0002-6556-0354); Welters, M.J.P.
Published
2016
Publication type
Article / Letter to editor
Human papillomavirusTumor-draining lymph nodeCervical cancerAdoptive cell transferHPV-specific T cellsGood manufacturing practice
Date issued
2016-12-31
Language
English
Is part of
Cancer Immunology, Immunotherapy (2016), Vol. 65, no. 12, p. 1451-1463
hdl
1887/111781
doi
10.1007/s00262-016-1892-8